Babybig Injection, Powder, Lyophilized, For Solution
Product Images NDC 68403-1100

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Babybig (NDC 68403-1100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by California Department Of Public Health, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (2 mL Vial Label)

Label for BabyBIG, a human botulinum neurotoxin a/b immune globulin injection in lyophilized powder form for intravenous use. The label includes usage instructions not to shake the vial after reconstitution and advises avoiding foaming. Manufactured for the California Department of Public Health by Baxalta Inc. and Cangene bioPharma Inc. The label also displays the product NDC 68403-1100-6, lot, and expiration placeholders.*

FDA Label Image

Principal Display Panel (1 Single Use Vial Carton)

Packaging label for BabyBIG injection, lyophilized powder for solution, containing Botulism Immune Globulin Intravenous (Human) (BIG-IV). The label indicates 100 mg IgG, 100 mg sucrose, and 20 mg human albumin per vial. It is for intravenous use, supplied by California Department of Public Health, with manufacturing by Baxalta Inc. and Cangene bioPharma Inc. Storage instructions specify 2°C to 8°C (35.6°F to 46.4°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.